David Conde-Estévez

6PUBLICATIONS
19CO-AUTHORS
Clinical pharmacology and therapeuticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBehavioural epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2025
Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage.

Cristina Ibáñez, Manuel Tourís-Lores, Álvaro Montesa

|Apr 10, 2023
GEDEFO-SEFH management of antineoplastic extravasations survey results.

Inmaculada Jiménez-Pulido, María Asunción Albert-Marí, David Conde-Estévez

|Apr 26, 2022
Antineoplastic extravasation management: Consensus of the Spanish Oncology Pharmacy Group (GEDEFO).

Asunción Albert-Marí, Inmaculada Jiménez-Pulido, Begoña San José-Ruiz

|Apr 12, 2022
Sézary syndrome patient-derived models allow drug selection for personalized therapy.

Fernando Gallardo, Evelyn Andrades, Arnau Iglesias

|Feb 18, 2022
Impact of drug safety warnings and antimicrobial stewardship programme implementation on tigecycline prescribing: a prospective quasi-experimental interrupted time series analysis.

Melisa Barrantes-González, Santiago Grau, David Conde-Estévez

|Aug 18, 2020
Monoclonal antibody extravasations: Two case reports and literature review.

Alicia Rodríguez-Alarcón, David Conde-Estévez

Pageof 1

Frequent Collaborators

2 joint publications

Begoña San José-Ruiz

2 joint publications

María Asunción Albert-Marí

2 joint publications

Inmaculada Jiménez-Pulido

1 joint publications

Arnau Iglesias